Glutamatergic Gene Expression Is Specifically Reduced in Thalamocortical Projecting Relay Neurons in Schizophrenia
暂无分享,去创建一个
Vahram Haroutunian | V. Haroutunian | J. Meador-Woodruff | R. Mccullumsmith | Micah Simmons | James H. Meador-Woodruff | Monsheel S. Sodhi | Robert McCullumsmith | Monsheel Sodhi | M. Simmons
[1] D J Healy,et al. Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia. , 2000, The American journal of psychiatry.
[2] J. Meador-Woodruff,et al. Role of glutamate in schizophrenia: integrating excitatory avenues of research , 2008, Expert review of neurotherapeutics.
[3] D. German,et al. Elevated neuron number in the limbic thalamus in major depression. , 2004, The American journal of psychiatry.
[4] Paul J. Harrison,et al. GluR2 glutamate receptor subunit flip and flop isoforms are decreased in the hippocampal formation in schizophrenia: a reverse transcriptase-polymerase chain reaction (RT-PCR) study. , 1997, Brain research. Molecular brain research.
[5] Nicolette Marshall,et al. Magnetic resonance imaging of the thalamus and adhesio interthalamica in twins with schizophrenia. , 2007, Archives of general psychiatry.
[6] V. Haroutunian,et al. Up‐regulation of NMDA receptor subunit and post‐synaptic density protein expression in the thalamus of elderly patients with schizophrenia , 2006, Journal of neurochemistry.
[7] Paul J. Harrison,et al. Glutamate Receptors and Transporters in the Hippocampus in Schizophrenia , 2003, Annals of the New York Academy of Sciences.
[8] J. Olney,et al. Glutamate receptor dysfunction and schizophrenia. , 1995, Archives of general psychiatry.
[9] B. Pakkenberg,et al. Schizophrenia; from structure to function with special focus on the mediodorsal thalamic prefrontal loop , 2009, Acta psychiatrica Scandinavica.
[10] J. Noga,et al. Further postmortem autoradiographic studies of AMPA receptor binding in schizophrenia , 2002, Synapse.
[11] J. Corwin,et al. Effects of d-cycloserine on negative symptoms in schizophrenia , 2004, Schizophrenia Research.
[12] P. Ward,et al. Selective Alterations in Ionotropic Glutamate Receptors in the Anterior Cingulate Cortex in Schizophrenia , 2002, Neuropsychopharmacology.
[13] Edward G Jones,et al. Vesicular glutamate transporters define two sets of glutamatergic afferents to the somatosensory thalamus and two thalamocortical projections in the mouse , 2008, The Journal of comparative neurology.
[14] V. Vingtdeux,et al. Calcium signaling in neurodegeneration , 2009, Molecular Neurodegeneration.
[15] B. Sokolov,et al. Expression of NMDAR1, GluR1, GluR7, and KA1 Glutamate Receptor mRNAs Is Decreased in Frontal Cortex of “Neuroleptic‐Free” Schizophrenics: Evidence on Reversible Up‐Regulation by Typical Neuroleptics , 1998, Journal of neurochemistry.
[16] D. Javitt,et al. Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia. , 1987, The Hillside journal of clinical psychiatry.
[17] G. Rosenbaum,et al. Study of a new schizophrenomimetic drug; sernyl. , 1959, A.M.A. archives of neurology and psychiatry.
[18] R W Neufeld,et al. Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy. , 1997, Archives of general psychiatry.
[19] J. Meador-Woodruff,et al. Abnormal Glutamate Receptor Expression in the Medial Temporal Lobe in Schizophrenia and Mood Disorders , 2007, Neuropsychopharmacology.
[20] Ravi S. Menon,et al. Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS. , 2003, The American journal of psychiatry.
[21] Richard A. Komoroski,et al. In vitro 1H-magnetic resonance spectroscopy of postmortem brains with schizophrenia , 1997, Biological Psychiatry.
[22] C. Houser,et al. Two Forms of the γ‐Aminobutyric Acid Synthetic Enzyme Glutamate Decarboxylase Have Distinct Intraneuronal Distributions and Cofactor Interactions , 1991, Journal of neurochemistry.
[23] F. Fumagalli,et al. Chronic phencyclidine administration reduces the expression and editing of specific glutamate receptors in rat prefrontal cortex , 2007, Experimental Neurology.
[24] R Freedman,et al. Differential modulation of gene expression in the NMDA postsynaptic density of schizophrenic and control smokers. , 2005, Brain research. Molecular brain research.
[25] D. German,et al. Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia , 2000, Biological Psychiatry.
[26] E. G. Jones,et al. Distribution of tachykinin- and enkephalin-immunoreactive fibers in the human thalamus , 1989, Brain Research Reviews.
[27] E. Jones. Functional subdivision and synaptic organization of the mammalian thalamus. , 1981, International review of physiology.
[28] T. Kuner,et al. Multiple Structural Elements Determine Subunit Specificity of Mg2+ Block in NMDA Receptor Channels , 1996, The Journal of Neuroscience.
[29] Marc G Caron,et al. Mice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia , 1999, Cell.
[30] Thomas Ragg,et al. The RIN: an RNA integrity number for assigning integrity values to RNA measurements , 2006, BMC Molecular Biology.
[31] F. Benes,et al. Increased density of glutamate-immunoreactive vertical processes in superficial laminae in cingulate cortex of schizophrenic brain. , 1992, Cerebral cortex.
[32] P. McKenna,et al. Gene expression of metabotropic glutamate receptor 5 and excitatory amino acid transporter 2 in the schizophrenic hippocampus. , 2000, Brain research. Molecular brain research.
[33] F. Goodwin,et al. Brain endolases as specific markers of neuronal and glial cells. , 1978, Science.
[34] F. Speleman,et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.
[35] Carol A. Tamminga,et al. Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia , 1995, Neuropsychopharmacology.
[36] J. Meador-Woodruff,et al. Thalamic dysfunction in schizophrenia: neurochemical, neuropathological, and in vivo imaging abnormalities , 2004, Schizophrenia Research.
[37] D. Lodge. The history of the pharmacology and cloning of ionotropic glutamate receptors and the development of idiosyncratic nomenclature , 2009, Neuropharmacology.
[38] C. McBain,et al. N-methyl-D-aspartic acid receptor structure and function. , 1994, Physiological reviews.
[39] V. Haroutunian,et al. N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia. , 2001, The American journal of psychiatry.
[40] J. Meador-Woodruff,et al. Abnormalities of the NMDA Receptor and Associated Intracellular Molecules in the Thalamus in Schizophrenia and Bipolar Disorder , 2004, Neuropsychopharmacology.
[41] R. Conley,et al. Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia. , 2000, The American journal of psychiatry.
[42] K. Newell,et al. Ionotropic glutamate receptor binding in the posterior cingulate cortex in schizophrenia patients , 2005, Neuroreport.
[43] Mary B. Kennedy,et al. Spine architecture and synaptic plasticity , 2005, Trends in Neurosciences.
[44] 石丸 昌彦. Increases in strychnine-insensitive glycine binding sites in cerebral cortex of chronic schizophrenics : evidence for glutamate hypothesis , 1994 .
[45] R. Huganir,et al. SynGAP regulates synaptic strength and mitogen-activated protein kinases in cultured neurons. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[46] A. Lajtha,et al. Reduced [3H]flunitrazepam binding in cingulate cortex and hippocampus of postmortem schizophrenic brains: Is selective loss of glutamatergic neurons associated with major psychoses? , 1993, Neurochemical Research.
[47] M. Burset,et al. Multiplex preamplification of specific cDNA targets prior to gene expression analysis by TaqMan Arrays , 2008, BMC Research Notes.
[48] A. Erisir,et al. VGluT2 immunochemistry identifies thalamocortical terminals in layer 4 of adult and developing visual cortex , 2005, The Journal of comparative neurology.
[49] J. Krystal,et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. , 1994, Archives of general psychiatry.
[50] J. Coyle,et al. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. , 2001, The American journal of psychiatry.
[51] K. Davis,et al. Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases. , 1998, Archives of general psychiatry.
[52] Paul J. Harrison,et al. Immunoautoradiographic evidence for a loss of α-amino-3-hydroxy-5-methyl-4-isoxazole propionate-preferring non-N-methyl-D-aspartate glutamate receptors within the medial temporal lobe in schizophrenia , 1997, Biological Psychiatry.
[53] C. Breese,et al. Glutamate receptor subtype expression in human postmortem brain tissue from schizophrenics and alcohol abusers , 1995, Brain Research.
[54] J. Pierri,et al. Altered Cortical Glutamate Neurotransmission in Schizophrenia , 2003 .
[55] E G Jones,et al. Subnucleus-specific loss of neurons in medial thalamus of schizophrenics. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[56] K. Sim,et al. Glutamatergic abnormalities of the thalamus in schizophrenia: a systematic review , 2008, Journal of Neural Transmission.
[57] M. Toru,et al. Increases in strychnine-insensiive glycine binding sites in cerebral cortex of chronic schizophrenics: Evidence for glutamate hypothesis , 1994, Biological Psychiatry.
[58] Mary B. Kennedy,et al. The postsynaptic density at glutamatergic synapses , 1997, Trends in Neurosciences.
[59] J. Meador-Woodruff,et al. Glutamate receptor expression in schizophrenic brain , 2000, Brain Research Reviews.
[60] J. Trojanowski,et al. Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex. , 2002, Archives of general psychiatry.
[61] E G Jones,et al. Cortical development and thalamic pathology in schizophrenia. , 1997, Schizophrenia bulletin.
[62] S. Hirsch,et al. NMDA receptor mRNA correlation with antemortem cognitive impairment in schizophrenia. , 1996, Neuroreport.
[63] J. Meador-Woodruff,et al. Molecular Abnormalities of the Glutamate Synapse in the Thalamus in Schizophrenia , 2003, Annals of the New York Academy of Sciences.
[64] Bert Sakmann,et al. Heteromeric NMDA Receptors: Molecular and Functional Distinction of Subtypes , 1992, Science.
[65] T. Nabeshima,et al. Animal Model of Schizophrenia , 2006, Annals of the New York Academy of Sciences.
[66] G. Rosenbaum,et al. Comparison of sernyl with other drugs: simulation of schizophrenic performance with sernyl, LSD-25, and amobarbital (amytal) sodium; I. Attention, motor function, and proprioception. , 1959, A.M.A. archives of general psychiatry.
[67] G. Rosenbaum,et al. Comparison of phencyclidine hydrochloride (Sernyl) with other drugs. Simulation of schizophrenic performance with phencyclidine hydrochloride (Sernyl), lysergic acid diethylamide (LSD-25), and amobarbital (Amytal) sodium; II. Symbolic and sequential thinking. , 1962, Archives of general psychiatry.
[68] N. Farber. The NMDA Receptor Hypofunction Model of Psychosis , 2003, Annals of the New York Academy of Sciences.
[69] L. Crepaldi,et al. Altered Dimerization of Metabotropic Glutamate Receptor 3 in Schizophrenia , 2007, Biological Psychiatry.
[70] J. Walecki,et al. The effect of risperidone on metabolite measures in the frontal lobe, temporal lobe, and thalamus in schizophrenic patients. A proton magnetic resonance spectroscopy (1H MRS). , 2005, Pharmacopsychiatry.
[71] William Byne,et al. Postmortem assessment of thalamic nuclear volumes in subjects with schizophrenia. , 2002, The American journal of psychiatry.
[72] J. Pierri,et al. Altered cortical glutamate neurotransmission in schizophrenia: evidence from morphological studies of pyramidal neurons. , 2003, Annals of the New York Academy of Sciences.
[73] D. Javitt,et al. Neurophysiological and neurochemical animal models of schizophrenia: Focus on glutamate , 2009, Behavioural Brain Research.
[74] William Byne,et al. Magnetic resonance imaging of mediodorsal, pulvinar, and centromedian nuclei of the thalamus in patients with schizophrenia. , 2003, Archives of general psychiatry.
[75] B. Dean,et al. Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder , 2007, Brain Research.
[76] E. Bullmore,et al. The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. , 2008, The American journal of psychiatry.
[77] A. Sampson,et al. Stereological analysis of the mediodorsal thalamic nucleus in schizophrenia: Volume, neuron number, and cell types , 2004, The Journal of comparative neurology.
[78] Ravi S. Menon,et al. Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers. , 2002, The American journal of psychiatry.
[79] Paul J. Harrison,et al. A postmortem study of the mediodorsal nucleus of the thalamus in schizophrenia , 2003, Schizophrenia Research.
[80] Joseph T. Coyle,et al. The Glutamatergic Dysfunction Hypothesis for Schizophrenia , 1996, Harvard review of psychiatry.
[81] V. Haroutunian,et al. mRNA expression of AMPA receptors and AMPA receptor binding proteins in the cerebral cortex of elderly schizophrenics , 2005, Journal of neuroscience research.
[82] V. Haroutunian,et al. Ionotropic glutamate receptor mRNA expression in the human thalamus: Absence of change in schizophrenia , 2008, Brain Research.
[83] R. Huganir,et al. Persistent hippocampal CA1 LTP in mice lacking the C-terminal PDZ ligand of GluR1 , 2005, Nature Neuroscience.
[84] G. Collingridge,et al. NMDA receptor dependence of mGlu‐mediated depression of synaptic transmission in the CA1 region of the rat hippocampus , 1996, British journal of pharmacology.
[85] J. Meador-Woodruff,et al. Abnormal striatal expression of transcripts encoding NMDA interacting PSD proteins in schizophrenia, bipolar disorder and major depression , 2005, Schizophrenia Research.
[86] Jones Eg. Functional subdivision and synaptic organization of the mammalian thalamus. , 1981 .
[87] K. Davis,et al. Metabotropic glutamate receptor mRNA expression in the schizophrenic thalamus , 2000, Biological Psychiatry.
[88] P. Slater,et al. Frontal Cortical and Left Temporal Glutamatergic Dysfunction in Schizophrenia , 1989, Journal of neurochemistry.
[89] K. Davis,et al. Abnormal Kainate Receptor Expression in Prefrontal Cortex in Schizophrenia , 2001, Neuropsychopharmacology.
[90] F. Benes,et al. GluR5,6,7 subunit immunoreactivity on apical pyramidal cell dendrites in hippocampus of schizophrenics and manic depressives , 2001, Hippocampus.
[91] L. Lapham,et al. Immunofluorescence staining of astrocytes in vitro using antiserum to glial fibrillary acidic protein , 1975, Brain Research.
[92] K. Davis,et al. Metabotropic glutamate receptor protein expression in the prefrontal cortex and striatum in schizophrenia , 2005, Synapse.